Tag Archives: sofosbuvir-ledipasvir

Hetero gets DCGI nod for generic Harvoni under the brand name Ledisof

HYDERABAD, DEC 8:  Generic pharmaceutical company Hetero today announced that it has received the approval for the fixed-dose combination Ledipasvir-Sofosbuvir (90mg/400mg) from the Drug Controller General of India (DCGI). The drug, Ledisof, is a generic version of Gilead Sciences’ brand Harvoni which is approved by the US FDA. The Hyderabad based Hetero had signed a […]

Testing Provisions Patient Safety

So what is this image? It is a patient safety check. Each coloured line represents a single patient’s self imported Sofosbuvir being tested against a reference standard. Yes it’s just lines but for each chemical there is a unique NMR signature represented by the spikes in those lines, but let’s rewind….. Back in February when […]

Patient Rights vs Patent Rights

The thing with Hep C is that it’s not about anonymous statistics, it’s about real people. Here’s the story of one patient, and his wife’s journey through Interferon and failure and then to self initiated treatment and cure via the parallel import of generic DAA medications that was published in the Sydney Morning Herald and […]

Factory making fake Hepatitis C drug raided

 Assisted by the Federal Investigation Authority (FIA), personnel of the Drug Regulatory Authority of Pakistan (DRAP) raided one of the local industries in Islamabad’s Kahuta industrial area here Saturday, leading to the discovery of unlawful manufacturing of Sofasbuvir tablets, which are used for the treatment of Hepatitis C…. Readmore at http://www.thenews.com.pk/Todays-News-6-304343-Factory-making-fake-Hepatitis-C-drug-raided  

WHO moves to improve access to lifesaving medicines for hepatitis C

GENEVA – WHO today published the new edition of its Model List of Essential Medicines which includes ground-breaking new treatments for hepatitis C. http://www.who.int/mediacentre/news/releases/2015/new-essential-medicines-list/en/ 

× Chat